Stevanato Group (NYSE:STVN) Issues Earnings Results, Misses Estimates By $0.01 EPS

Key Points

• Stevanato Group reported quarterly EPS of €0.11, missing analyst expectations by €0.01, while revenue came in at €273.57 million.
• Revenue rose 6.6% from the same quarter a year ago, and the company posted a net margin of 11.83% with return on equity of 10.44%.
• The stock traded up 1.1% on the day, and analysts currently have a consensus Hold rating on STVN.

Stevanato Group (NYSE:STVN - Get Free Report) released its quarterly earnings data on Friday. The company reported €0.11 EPS for the quarter, missing analysts' consensus estimates of €0.12 by (€0.01), Briefing.com reports. Stevanato Group had a net margin of 11.83% and a return on equity of 10.44%. The business had revenue of €273.57 million during the quarter. During the same quarter in the previous year, the company earned $0.10 EPS. The business's revenue was up 6.6% compared to the same quarter last year.

Stevanato Group Stock Up 1.1%

Shares of Stevanato Group stock traded up €0.20 during trading hours on Friday, reaching €18.23. 655,785 shares of the company were exchanged, compared to its average volume of 671,758. Stevanato Group has a 1 year low of €12.89 and a 1 year high of €28.00. The stock's fifty day moving average is €15.16 and its 200 day moving average is €18.75. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.26 and a current ratio of 1.76. The firm has a market cap of $5.52 billion, a PE ratio of 31.43, a PEG ratio of 1.70 and a beta of 0.75.

Institutional Trading of Stevanato Group

A number of large investors have recently modified their holdings of STVN. GW&K Investment Management LLC increased its position in shares of Stevanato Group by 76.2% during the fourth quarter. GW&K Investment Management LLC now owns 2,440 shares of the company's stock worth $49,000 after acquiring an additional 1,055 shares during the period. State of Wyoming increased its position in shares of Stevanato Group by 39,216.7% during the second quarter. State of Wyoming now owns 2,359 shares of the company's stock worth $58,000 after acquiring an additional 2,353 shares during the period. Quantbot Technologies LP purchased a new stake in shares of Stevanato Group during the third quarter worth $68,000. Tower Research Capital LLC TRC increased its holdings in Stevanato Group by 1,268.7% in the second quarter. Tower Research Capital LLC TRC now owns 4,585 shares of the company's stock valued at $112,000 after buying an additional 4,250 shares during the last quarter. Finally, Walleye Capital LLC purchased a new position in Stevanato Group in the fourth quarter valued at $214,000.

Analyst Ratings Changes

A number of research analysts recently commented on the company. Citigroup decreased their price objective on Stevanato Group from $32.00 to $26.00 and set a "buy" rating on the stock in a report on Thursday, March 5th. Weiss Ratings cut Stevanato Group from a "hold (c-)" rating to a "sell (d+)" rating in a report on Wednesday, March 11th. KeyCorp cut their target price on Stevanato Group from $37.00 to $32.00 and set an "overweight" rating on the stock in a research report on Thursday, March 5th. Wall Street Zen lowered Stevanato Group from a "buy" rating to a "hold" rating in a research report on Saturday, February 14th. Finally, Jefferies Financial Group set a $17.50 target price on Stevanato Group in a research report on Tuesday, February 10th. Three analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, Stevanato Group has a consensus rating of "Hold".

About Stevanato Group

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.